Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.

Explorateur d’archives

Parcourir et rechercher des captures

Note importante

Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.

Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.

Parcourir les sites archivés

Parcourir toutes les sources →

Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca Skip to "About…

URL d’originewww.canada.ca/en/public-health/services/publications/healthy-living/update-use-of-13-valent-pneumococcal-conjugate-vaccine-pneu-c-13-in-addition-to-23-valent-pneumococcal-polysaccharide-vaccine-pneu-p-23-immunocompetent-adults-65-years-and-older-interim-recommendation.html

Re-Immunization with Polysaccharide 23-Valent Pneumococcal Vaccine (Pneu-P-23) - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Re-Immunization with Polysaccharide 23-Valent Pneumococcal Vaccine (Pneu-P-23) - Canada.ca Français fr / Search Search Canada.ca Search Jobs and the workplace Immigration and…

URL d’originewww.canada.ca/en/public-health/services/publications/healthy-living/re-immunization-with-polysaccharide-23-valent-pneumococcal-vaccine-pneu-p-23.html

Economic evidence supplementary appendix : Recommendations for public health programs on the use of pneumococcal vaccines in children - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Economic evidence supplementary appendix : Recommendations for public health programs on the use of pneumococcal vaccines in children - Canada.ca Français fr / Search Search Canada.ca Search…

URL d’originewww.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-recommendations-public-health-programs-use-pneumococcal-vaccines-children-including-use-15-valent-20-valent-conjugate-vaccines-economic-evidence-supplementary-appendix.html

Summary: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine in pediatric populations in Canada: NACI, March 21, 2023 - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Summary: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine in pediatric populations in Canada: NACI, March 21, 2023 - Canada.ca Français fr / Search Search Canada.ca…

URL d’originewww.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-interim-guidance-pneumococcal-15-valent-conjugate-vaccine-pneu-c-15-pediatric-populations-march-2023.html

Interim guidance on the use of pneumococcal 15-valent conjugate vaccine in pediatric populations in Canada: NACI, March 21, 2023 - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Interim guidance on the use of pneumococcal 15-valent conjugate vaccine in pediatric populations in Canada: NACI, March 21, 2023 - Canada.ca Français fr / Search Search Canada.ca Search Menu…

URL d’originewww.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-interim-guidance-pneumococcal-15-valent-conjugate-vaccine-pneu-c-15-pediatric-populations.html

Vaccination Coverage Goals and Vaccine Preventable Disease Reduction Targets by 2025 - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Vaccination Coverage Goals and Vaccine Preventable Disease Reduction Targets by 2025 - Canada.ca Français fr / Search Search Canada.ca Search Jobs and the workplace…

URL d’originewww.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html

Update on the use of pneumococcal vaccines in adults 65 years of age and older – A Public Health Perspective - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Update on the use of pneumococcal vaccines in adults 65 years of age and older – A Public Health Perspective - Canada.ca Français fr / Search Search Canada.ca Search Jobs and…

URL d’originewww.canada.ca/en/public-health/services/publications/healthy-living/update-on-the-use-of-pneumococcal-vaccines-in-adult.html

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: NACI recommendations: Economic evidence supplementary appendixrecommendations. - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: NACI recommendations: Economic evidence supplementary appendixrecommendations. - Canada.ca Français fr /…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines/economic-evidence-supplementary-appendix.html

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Summary of NACI Statement of February 2023 - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Summary of NACI Statement of February 2023 - Canada.ca Français fr / Search Search…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines/summary-february-2023.html

Use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines: NACI public health level recommendations. - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines: NACI public health level recommendations. - Canada.ca Français fr / Search Search…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines.html
Page 3902 sur 3977Affichage de 39011 à 39020 sur 39762
« Première← Préc.Suiv. →Dernière »

Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.